Prediction of Prostate Cancer Risk Stratifications Based on A Non-Linear Transformation Stacking Learning Strategy

Author:

cao xinyu,Fang Yin,Yang Chunguang,Liu Zhenghao,Wu Xinglong

Abstract

Abstract Prostate cancer (PCa) is an epithelial malignancy that occurs in the prostate gland and is generally classified into three risk categories: low, intermediate, and high risk. The most important diagnostic indicator for PCa is the measurement of serum prostate-specific antigen (PSA) values, but this method can produce false positives leading to unnecessary biopsies, increasing the likelihood of invasive injuries. Therefore, it is imperative to develop an efficient and accurate method to predict PCa risk stratifications. Most current studies on predictions of PCa risk stratification based on clinical data generally perform only a dichotomy of low to intermediate and high risk. This paper proposed a novel machine learning (ML) approach based on a Stacking learning strategy to predict tripartite risk stratifications of PCa. Clinical records with features selected by Lasso were learned by five ML classifiers. Outputs of five classifiers were transformed by various nonlinear transformers (NT) and then, concatenated with the Lasso-selected features to obtain a set of new features. A Stacking learning strategy integrating different ML classifiers was developed based on these new features. Our proposed approach achieved superior performance with an accuracy (ACC) of 0.83 and an Area Under the Receiver Operating Characteristic curve (AUC) value of 0.88 in a dataset of 197 PCa patients with 42 clinical characteristics. This study will better assist clinicians in rapidly assessing PCa risk stratifications while reducing patient burden through AI-related technologies in auxiliary diagnosis of PCa.

Publisher

Research Square Platform LLC

Reference33 articles.

1. Prostate Cancer - Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/prost.html.

2. Risk factors for prostate cancer;Pienta KJ;Annals of internal medicine,1993

3. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge;Bulten W;Nature medicine,2022

4. Medium-term outcomes of active surveillance for localised prostate cancer;Selvadurai ED;European urology,2013

5. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options;Sanda MG;The Journal of urology,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3